Cargando…

Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates

AIMS: Assessing reversibility of pulmonary vascular changes through vasoreactivity testing (VRT) optimizes end‐stage heart failure patient selection for heart transplant. All efforts should be made to unload the left ventricle and reduce pulmonary vascular resistance to effectively exclude irreversi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavares‐Silva, Marta, Saraiva, Francisca, Pinto, Roberto, Amorim, Sandra, Silva, João Carlos, Leite‐Moreira, Adelino F., Maciel, Maria Júlia, Lourenço, André P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006659/ https://www.ncbi.nlm.nih.gov/pubmed/33621427 http://dx.doi.org/10.1002/ehf2.13168

Ejemplares similares

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)

Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
por: Yıldırım, Şükran
Publicado: (2023)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
por: Loureiro, Maria José, et al.
Publicado: (2007)

Inhaled Iloprost for Patients With Precapillary Pulmonary Hypertension and Right-Side Heart Failure
por: Martischnig, Amadea M., et al.
Publicado: (2011)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
por: Wang, Lan, et al.
Publicado: (2017)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

Inhaled iloprost for the treatment of patient with Fontan circulation
por: Kim, Yong Hyun, et al.
Publicado: (2014)

Effects of inhaled iloprost on right ventriculovascular coupling and ventricular interdependence in acute pulmonary hypertension
por: Rex, S, et al.
Publicado: (2008)

Efficacy of Inhaled Iloprost in Cor Pulmonale and Severe Pulmonary Hypertension Associated with Tuberculous Destroyed Lung
por: Park, Yae Min, et al.
Publicado: (2014)

The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension
por: Nakayama, Kazuhiko, et al.
Publicado: (2018)

Role of inhaled levosimendan in peripartum cardiomyopathy
por: Kaur, Parminder, et al.
Publicado: (2022)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP)
por: Stollfuss, Barbara, et al.
Publicado: (2021)

Effects of inhaled iloprost on acute respiratory distress syndrome in prone and supine positions
por: Senturk, E, et al.
Publicado: (2009)

Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
por: Serbanescu-Kele Apor de Zalán, Christiaan M.C., et al.
Publicado: (2022)

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013)

Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
por: Li, Jing-Hui, et al.
Publicado: (2019)

Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy
por: Yasuda, Kenichiro, et al.
Publicado: (2022)

Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series
por: Colglazier, Elizabeth, et al.
Publicado: (2023)

Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension
por: Burger, Charles D, et al.
Publicado: (2023)

Long‐term prognostic value of cardiac catheterization and acute vasodilator testing with inhaled iloprost in pediatric idiopathic pulmonary arterial hypertension
por: Zhang, Chen, et al.
Publicado: (2022)

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
por: Tsareva, Natalia A., et al.
Publicado: (2021)

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment
por: Miller, York E., et al.
Publicado: (2023)

Alterações da Rigidez Arterial em Pacientes com Estenose Aórtica Grave Submetidos à Cirurgia de Troca Valvar
por: Raimundo, Renata, et al.
Publicado: (2021)

Body mass index effect on long-term survival after coronary artery bypass surgery: a competing risk analysis
por: Abreu, Armando, et al.
Publicado: (2023)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Magnan, Marie-Anne, et al.
Publicado: (2021)

Efficacy of inhaled iloprost in the management of pulmonary hypertension after cardiopulmonary bypass in infants undergoing congenital heart surgery. A case series of 31 patients
por: Müller, M, et al.
Publicado: (2011)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study
por: Mueller, Christian, et al.
Publicado: (2019)

Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches
por: Martinho, Sofia, et al.
Publicado: (2020)

Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis
por: Song, Ci, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8vspje50u3g1ir2hnt4n5tcjd